Skip to main content

Table 1 Clinicopathological characteristics of patients

From: Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma

ID Age Gender ENSAT 2008 Stage Metastasis Diameter Hormonal profile Recurrence
C1 58 F III N 13 cm Non-functional Y
C2 32 F III N 12 cm Androgen-producing N
C3 62 F III Y 14 cm Cortisol-producing Y
C4 48 M III N 9 cm Non-functional N
C5 48 F III N 13 cm Cortisol-producing Y
C6 55 F IV Y 5.5 cm Cortisol-producing Y
C7 60 F IV Y 7.8 cm Cortisol-producing Y
  1. Diverse clinical and pathological characteristics of adrenocortical cancer (n = 7) patients selected for the study, is shown. ENSAT 2008 Staging: European Network for the Study of Endocrine Tumors; Y = Yes, N = No, F = Female, M = Male.